Effects of satavaptan, a selective vasopressin V2 receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatrmia: A randomized trial

Abstract

Cirrhosis, hyponatremia

Keywords

• Hyponatremia
• Cirrhosis